Navigation Links
Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
Date:12/9/2008

Data Showed Campath May Lead to Overall Survival in Patients with Poor Prognostic Factors

SAN FRANCISCO, Dec. 9 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced results from three studies showing that treatment with Campath(R) (alemtuzumab) showed activity in high-risk chronic lymphocytic leukemia (CLL) patients who have poor prognostic indicators. These findings were presented at the 50th Annual Meeting of the American Society of Hematology in San Francisco, California.

Treatment for CLL can be complicated by genetic risk factors. In some cases of CLL, at least one of the 23 pairs of chromosomes in a cell is found to be either deleted or part of it is lost. One deletion that is occasionally seen in CLL patients is the loss of the short arm of chromosome 17 (17p deletion), which may indicate a poor prognosis including significantly inferior survival compared to other CLL patients. Past studies have shown that treatment naive CLL patients were less likely to have 17p deletions than previously treated patients with CLL, indicating that cytogenetic abnormalities may be acquired during the course of treatment. Effective CLL therapies for patients with 17p deletion are limited.

In one analysis of high-risk patients (abstract #3164), authors used the largest database available on the efficacy of Campath monotherapy to conduct a retrospective analysis of Campath treatment in 138 patients with advanced CLL, stratified according to cytogenetics. Of these patients, 33 percent had the 17p deleted cytogenetic abnormality. Campath administration was found to provide an overall response rate [ORR; complete response rate (CRR) + partial response rate (PRR)] of 38 percent in the total cohort, and an ORR of 44 percent in patients with 17p deletion. Additionally, in patients with 17p deletion, treatment with Campath resulted in progression free survival (PFS) and overall survival (OS) of 7.1 month
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Restore Health, a ... compounded pharmaceuticals, announced that it is now offering ... to each individual based upon their particular genetic ... understanding the interaction between a patient,s genetics and ... very excited to provide this new service to ...
(Date:7/24/2014)... 24, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the first fiscal ... overview: , Revenues of $47.5 million, up 10% ... of $0.21, up 50% over last year,s comparable quarter. ... of $7.2 million, up 20% over last year,s comparable ...
(Date:7/24/2014)... 24, 2014 Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... 31, to discuss the Company,s Second Quarter 2014 ... 2014 earnings conference call and webcastWhen: , ... Lipps, chairman, president and chief executive officer ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... Food and Drug Administration (FDA) says children and pets should not come in contact with ... menopause. , , , ... , , ... , The agency also wants ...
... AUSTIN, Texas ,  July 29 Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics ... issuance of Q2 financial results on Monday, August 16, 2010 . , ... Conference Call Information , , ... live conference call via phone, dial (800) 757 8521 from the United States ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3
(Date:7/26/2014)... July 26, 2014 The report “Gourmet ... Himalayan Salt, Flake Salt, Specialty Salt), Application (Bakery & ... Savory) & Geography - Global Trend & Forecast to ... analyses and projection of the market size in terms ... and restraining factors for the gourmet salts market, with ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 The European gas ... Europe with analysis and forecast of revenue. The gas chromatography ... in 2013, and is estimated to grow to around $445.5 ... 2013 to 2018. , Browse through the TOC of the ... the in-depth analysis provided. This report also provides a glimpse ...
(Date:7/26/2014)... “Today, we introduce our new items of ... the world. All these models are offered at discounted ... UK market,” says the CEO of the company. DressesOnlineShops.co.uk ... special occasion outfits. , Ladies have to find a ... one of the best choices for many ladies worldwide ...
(Date:7/26/2014)... 26, 2014 According to ... by Vkool.com, this is a comprehensive guide ... for treating all types of disorders ...     Tinnitus due to Ménière's disease , ...     Nerve pathway tinnitus ,     Inner, middle ...
(Date:7/26/2014)... ON (PRWEB) July 26, 2014 Studio B ... type of implant, often called Teeth in a Day, gives ... with a full set of bright, pearly whites with very ... teeth are permanent, look and feel just like natural teeth, ... and regular checkups. Studio B Dental is one of ...
Breaking Medicine News(10 mins):Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 2Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 3Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:Famous Supplier DressesOnlineShops.co.uk Announces Its New Selection of Prom Dresses for the UK Market 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2
... of the latest fleet golf car and the role ... a leader in,manufacturing execution systems (MES) for the integrated ... event,titled "Launching the E-Z-GO Fleet Golf Car: Integrating Manufacturing,Execution ... place on Thursday, March 6, 2008 at 2:00 p.m. ...
... accuracy with Microsoft Dynamics ... ... AliMed, a producer and catalog-based distributor of medical,products, has chosen Microsoft ... business and expanding its interaction with,customers. The technology will enable AliMed ...
... DENVER, March 4 Global Med Technologies(R),Inc. ... GLOB), an,international e-Health, medical information technology company, will ... Monday, March 10, 2008, before,the market open. The ... p.m. EDT,on the same day., (Logo: ...
... or tablets avoid the pain and side effects of shots, ... allergy immunotherapy -- in the form of drops or tablets ... for asthma medications in children who have what,s known as ... hopes that these oral medications might someday replace injections, never ...
... March 4 The number of Arab,Americans is ... second largest,concentration of people of Arab descent outside ... grows, so do their healthcare needs. Like many,other ... and educational challenges in accessing health information and,care., ...
... Patient Citizens Promotes National Kidney Month Programs to,Combat ... Nationwide -, WASHINGTON, March 4 DaVita ... comprised of more than 22,000,dialysis and pre-dialysis patients ... life for all dialysis patients through education and,advocacy ...
Cached Medicine News:Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 2Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 4Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 5Health News:Global Med Technologies(R), Inc. to Announce Fourth Quarter and Year End Results on Monday, March 10, 2008 2Health News:Global Med Technologies(R), Inc. to Announce Fourth Quarter and Year End Results on Monday, March 10, 2008 3Health News:Oral Allergy Immunotherapy Helps Control Asthma 2Health News:Oral Allergy Immunotherapy Helps Control Asthma 3Health News:International and Domestic Leaders to Convene to Tackle Health Issues in the Arab American Community 2Health News:Kidney Patient Advocacy Community Joins National Effort to Raise Awareness about Health Crisis Impacting more than 26 Million Americans 2
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Custom-made chisels....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Medicine Products: